GeneDx

👥 201-500💰 $150.0m Post-IPO Equity on 2023-01-27🫂 on 2022-11-14Artificial Intelligence (AI)MedicalPredictive AnalyticsMachine LearningAnalyticsHealth CareHealth Diagnostics
Website LinkedIn Email Phone # Facebook Twitter

GeneDx is a company focused on delivering personalized, actionable health insights by combining genomic expertise with data science, offering innovative solutions at the intersection of diagnostics and clinical data interpretation.